Smith, Salley & Associates Neogenomics Inc Transaction History
Smith, Salley & Associates
- $1.35 Billion
- Q2 2024
Shares
2 transactions
Others Institutions Holding NEO
# of Institutions
278Shares Held
127MCall Options Held
581KPut Options Held
107K-
Black Rock Inc. New York, NY19.7MShares$290 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$208 Million0.0% of portfolio
-
Brown Advisory Inc8.77MShares$129 Million0.16% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.73MShares$99.3 Million0.06% of portfolio
-
Janus Henderson Group PLC London, X06.62MShares$97.6 Million0.05% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.86B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...